We are live on ! Find out more
DA

DCF Advisers Portfolio holdings

AUM $375M
1-Year Est. Return 72.65%
This Fund
S&P 500
This Quarter Est. Return
+9.3%
1 Year Est. Return
+72.65%
3 Year Est. Return
+156.29%
5 Year Est. Return
+218.72%
10 Year Est. Return
–
AUM
$282M
AUM Growth
+$52.2M
Cap. Flow
+$37.1M
Cap. Flow %
13.15%
Top 10 Hldgs %
53.18%
Holding
123
New
20
Increased
19
Reduced
30
Closed
30

Top Buys

Rank Stock Value
1
GDX icon
VanEck Gold Miners ETF
GDX
+$2.1M
2
ALT icon
Altimmune
ALT
+$1.99M
3
PFE icon
Pfizer
PFE
+$1.94M
4
PSFE icon
Paysafe
PSFE
+$1.38M
5
F icon
Ford
F
+$1.2M

Top Sells

Rank Stock Value
1
ORCL icon
Oracle
ORCL
+$3.33M
2
ABBV icon
AbbVie
ABBV
+$2.82M
3
T icon
AT&T
T
+$1.96M
4
ITCI
Intra-Cellular Therapies Inc.
ITCI
+$1.83M
5
GLD icon
SPDR Gold Trust
GLD
+$1.7M

Sector Composition

Rank Sector Weight
1 Healthcare 28.83%
2 Technology 11.75%
3 Communication Services 8.8%
4 Financials 4.55%
5 Consumer Discretionary 3.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ESPR
101
DELISTED
Esperion Therapeutics
ESPR
– –
-17,286
Closed -$485K
F icon
102
CALL
Ford
F
$58.5B
– –
-20,000
Closed -$245K
KYNB
103
Kyntra Bio
KYNB
$27.2M
– –
-685
Closed -$594K
FMS icon
104
Fresenius Medical Care
FMS
$13.8B
– –
-43,400
Closed -$1.6M
FXI icon
105
CALL
iShares China Large-Cap ETF
FXI
$4.37B
– –
-8,000
Closed -$373K
GILD icon
106
CALL
Gilead Sciences
GILD
$162B
– –
-5,000
Closed -$323K
GILD icon
107
PUT
Gilead Sciences
GILD
$162B
– –
-10,000
Closed -$646K
IBB icon
108
CALL
iShares Biotechnology ETF
IBB
$9.34B
– –
-5,000
Closed -$753K
IBB icon
109
PUT
iShares Biotechnology ETF
IBB
$9.34B
– –
-35,000
Closed -$5.27M
LOW icon
110
Lowe's Companies
LOW
$117B
– –
-7,500
Closed -$1.43M
NVDA icon
111
CALL
NVIDIA
NVDA
$4.86T
– –
-16,000
Closed -$214K
NVDA icon
112
NVIDIA
NVDA
$4.86T
– –
-40,000
Closed -$534K
PG icon
113
PUT
Procter & Gamble
PG
$336B
– –
-7,500
Closed -$1.02M
QQQ icon
114
PUT
Invesco QQQ Trust
QQQ
$453B
– –
-23,000
Closed -$7.34M
SPCE icon
115
Virgin Galactic
SPCE
$328M
– –
-925
Closed -$567K
SPY icon
116
CALL
State Street SPDR S&P 500 ETF Trust
SPY
$790B
– –
-5,000
Closed -$1.98M
TBT icon
117
ProShares Trust UltraShort Lehman 20+ Year Treasury
TBT
$304M
– –
-9,500
Closed -$207K
TDC icon
118
Teradata
TDC
$2.92B
– –
-7,500
Closed -$289K
TGT icon
119
Target
TGT
$65.6B
– –
-5,000
Closed -$990K
UVXY icon
120
CALL
ProShares Ultra VIX Short-Term Futures ETF
UVXY
$224M
– –
-15
Closed -$206K
UVXY icon
121
ProShares Ultra VIX Short-Term Futures ETF
UVXY
$224M
– –
-5
Closed -$75K
VZ icon
122
CALL
Verizon
VZ
$195B
– –
-12,500
Closed -$727K
VBIV
123
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
– –
-867
Closed -$81K
1 2 3 4
5

Similar funds

JIC
JRM Investment Counsel Omaha, Nebraska $375M AUM 13.43% 1-Year Est. Return
CIM
CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return
AIM
Access Investment Management Atlanta, Georgia $376M AUM 17.2% 1-Year Est. Return
MWM
McMill Wealth Management Norfolk, Nebraska $376M AUM 14.46% 1-Year Est. Return
RCP
RIT Capital Partners London, United Kingdom $374M AUM 25.18% 1-Year Est. Return
HPM
Helix Partners Management New York $374M AUM 136.73% 1-Year Est. Return
CAG
Compass Advisory Group Melville, New York $374M AUM 14.59% 1-Year Est. Return
LWMNY
Landmark Wealth Management (New York) Melville, New York $373M AUM 12.01% 1-Year Est. Return

DCF Advisers's Q2 2021 Portfolio in Review

As of Q2 2021, DCF Advisers held 123 positions worth $282M, up 23% from $230M the previous quarter. Its ten largest holdings account for 53% of the portfolio.

DCF Advisers deployed $37.1M of net new capital in Q2 2021, opening 20 new positions and adding to 19 existing holdings. Its largest new stake was Altimmune: 145,750 shares worth $1.44M.

By sector, the portfolio is most concentrated in Healthcare at 29% of assets, down from 35% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was Oracle, an estimated $3.33M trimmed.

  • DCF Advisers's largest Q2 2021 buy was Altimmune: 145,750 shares worth $1.44M.
  • DCF Advisers added most to VanEck Gold Miners ETF in Q2 2021, an estimated $2.1M increase.
  • DCF Advisers's biggest Q2 2021 reduction was Oracle, cutting an estimated $3.33M.
  • DCF Advisers fully exited CVS Health in Q2 2021, selling an estimated $1.62M.
  • DCF Advisers's ten largest holdings make up 53% of its $282M portfolio in Q2 2021.
  • DCF Advisers opened 20 new positions and closed 30 in Q2 2021.
  • DCF Advisers's portfolio value rose 23% quarter-over-quarter to $282M.

Based on DCF Advisers's 13F filing for Q2 2021, filed 13 Aug 2021.